Camillo Ricordi, M.D.
Dr. Ricordi spent four years (1989-1993) as Director of Cellular Transplantation at the University of Pittsburgh Transplantation Institute. Since 1993, he has been at the University of Miami, where he holds the Stacy Joy Goodman Chair. He serves as Professor of Surgery, Medicine, Biomedical Engineering, Pathology, Microbiology and Immunology. Dr. Ricordi is also Chief of the Division of Cellular Transplantation, Department of Surgery, and Scientific Director and Chief Academic Officer of the Diabetes Research Institute. Dr. Ricordi was president of the Cell Transplant Society (1992-94), co-founder of the National Diabetes Research Coalition (Chairman 1997) and president of the International Association for Pancreas and Islet Transplantation (1999-2001; IPITA). Currently a member of the council of the International Transplantation Society, he also served on the council of the American Society of Transplant Surgeons (2000-2002). Dr. Ricordi is also serving on the NIH/NCRR Islet Cell Resources (ICRs) Executive Committee, as Chairperson of the Clinical Islet Transplant Consortium (NIDDK-NIAID), on the NIH-NIDDK Strategic Planning Committee, and on the NIH Expert Panel on Transplantation Research. Dr. Ricordi is also known for inventing the machine (pictured) that made it possible to isolate large numbers of islet cells from the human pancreas. He performed the first series of clinical islet transplants that reversed diabetes after implantation of donor purified islets into the liver of recipients with diabetes.
Return to Who is in the CIT Consortium